Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
1.135
-0.095 (-7.72%)
Aug 14, 2025, 1:50 PM - Market open
Aethlon Medical Employees
Aethlon Medical had 9 employees as of March 31, 2025. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
n/a
Profits / Employee
-$1,397,612
Market Cap
2.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AEMD News
- 18 hours ago - Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 21 hours ago - Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update - PRNewsWire
- 9 days ago - Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025 - PRNewsWire
- 4 weeks ago - Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort - PRNewsWire
- 6 weeks ago - Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update - PRNewsWire
- 7 weeks ago - Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025 - PRNewsWire
- 2 months ago - Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial - PRNewsWire